Pedron T, Girard R, Chaby R
Molecular Immunophysiology Unit, URA-1961, National Center for Scientific Research, Pasteur Institute, Paris, France.
FEMS Immunol Med Microbiol. 2000 Jul;28(3):247-56. doi: 10.1111/j.1574-695X.2000.tb01484.x.
Lipopolysaccharide (LPS) of Gram-negative bacteria interacts with a CD14-independent receptor of mouse bone marrow granulocytes (BMC), and triggers in these cells the expression of CD14, an inducible type of LPS receptor (iLpsR). This particular response of BMC to LPS required the activation of protein tyrosine kinase and p38 MAP kinase. The inhibition of the LPS effect by the MEK inhibitor PD-98059 suggested that the ERK pathway was also involved. Unexpectedly, protein kinase C, myosin light chain kinase, cAMP-, cGMP-, and Ca(2+)/calmodulin-dependent kinases, as well as ecto-protein kinases, were not required for iLpsR expression. However, other yet unidentified serine/threonine protein kinase(s) were implied since the BMC response to LPS was markedly reduced after exposure to three inhibitors of such kinases (K-252a, H-7, and KT-5823). The atypical kinase requirements observed in this study may be due either to a novel signaling LPS receptor complex present in BMC, or to the particular events involved in CD14 biosynthesis.
革兰氏阴性菌的脂多糖(LPS)与小鼠骨髓粒细胞(BMC)的一种不依赖CD14的受体相互作用,并在这些细胞中触发CD14的表达,CD14是一种可诱导型LPS受体(iLpsR)。BMC对LPS的这种特殊反应需要蛋白酪氨酸激酶和p38丝裂原活化蛋白激酶的激活。MEK抑制剂PD-98059对LPS效应的抑制表明ERK途径也参与其中。出乎意料的是,iLpsR表达不需要蛋白激酶C、肌球蛋白轻链激酶、cAMP依赖性激酶、cGMP依赖性激酶、Ca(2+)/钙调蛋白依赖性激酶以及胞外蛋白激酶。然而,由于BMC在暴露于三种此类激酶抑制剂(K-252a、H-7和KT-5823)后对LPS的反应明显降低,因此暗示了其他尚未确定的丝氨酸/苏氨酸蛋白激酶。本研究中观察到的非典型激酶需求可能是由于BMC中存在一种新型的LPS信号受体复合物,或者是由于CD14生物合成中涉及的特定事件。